title: FOLFIRI with cetuximab or bevacizumab: FIRE-3.
authors.affiliation: The Queen Elizabeth Hospital and University of Adelaide, Woodville, SA 5011, Australia. Electronic address: timothy.price@health.sa.gov.au.
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Price
authors.affiliation: The Queen Elizabeth Hospital and University of Adelaide, Woodville, SA 5011, Australia.
authors.forename: Amanda R
authors.initials: AR
authors.lastname: Townsend
authors.affiliation: Antwerp University Hospital and University of Antwerp, Edegem, Belgium.
authors.forename: Marc
authors.initials: M
authors.lastname: Peeters
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002166:Camptothecin / Q000031:analogs & derivatives*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D002166:Camptothecin